期刊
SMALL
卷 7, 期 6, 页码 705-717出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201001347
关键词
-
类别
资金
- Science Foundation Ireland [07/SRC/B1163]
- Programme for Third Level Institutions (PRTLI)
- Science Foundation Ireland (SFI) [07/SRC/B1163] Funding Source: Science Foundation Ireland (SFI)
Nanotechnology has the potential to revolutionize the management and treatment of cardiovascular disease. Controlled drug delivery and nanoparticle-based molecular imaging agents have advanced cardiovascular disease therapy and diagnosis. However, the delivery vehicles (dendrimers, nanocrystals, nanotubes, nanoparticles, nanoshells, etc.), as well as the model systems that are used to mimic human cardiac disease, should be questioned in relation to their suitability. This review focuses on the variations of the biological assays and preclinical models that are currently being used to study the biocompatibility and suitability of nanomaterials in cardiovascular applications. There is a need to standardize appropriate models and methods that will promote the development of novel nanomaterial-based cardiovascular therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据